Table 4.
Number of calves being Rotavirus, Coronavirus or E. coli K99 coproantigen-positive at least once and number of positive fecal samples during days 4–21 post-partum.
| Coproantigen | Treatment group | N1 (%) calves | N1 (%) fecal samples |
|---|---|---|---|
| Rotavirus | CON | 11/41 (26.8)a | 18/571 (3.2)a |
| SCFP | 15/41 (36.6)a | 23/572 (4.0)a | |
| HALO | 11/40 (26.8)a | 19/570 (3.3)a | |
| Coronavirus | CON | 0/41 (0)a | 0/571 (0)a |
| SCFP | 1/41 (2.4)a | 1/572 (0.2)a | |
| HALO | 2/40 (4.9)a | 2/570 (0.4)a | |
| E. coli K99 | CON | 10/41 (24.4)a | 13/571 (2.3)a |
| SCFP | 7/41 (17.1)a | 12/572 (2.1)a | |
| HALO | 9/40 (22.9)a | 14/570 (2.5)a |
Values of respective coproantigen with the same superscript in a column are not significantly different (p > 0.05).
Number of positive calves or samples/total number of calves or samples.